Inside Novo Nordisk A/S's Kalundborg Manufacturing Hub
The Novo Nordisk A/S factory complex in Kalundborg, Denmark, on Friday, May 24, 2024. Novo is spending $8 billion to expand its plant in rural Denmark produce more semaglutide, the key ingredient in its diabetes and weight-loss drugs. Photographer: Nanna Navntoft/Bloomberg via Getty Images
PURCHASE A LICENCE
How can I use this image?
£275.00
GBP
Getty ImagesInside Novo Nordisk A/S's Kalundborg Manufacturing Hub, News PhotoInside Novo Nordisk A/S's Kalundborg Manufacturing Hub Get premium, high resolution news photos at Getty ImagesProduct #:2155229088
£375£150
Getty Images
In stockDETAILS
Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Editorial #:
2155229088
Collection:
Bloomberg
Date created:
24 May, 2024
Upload date:
Licence type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
DENMARK NOVO
Max file size:
5352 x 8024 px (45.31 x 67.94 cm) - 300 dpi - 15 MB